
Mary M. Barna, PharmD
Advertisement
Articles by Mary M. Barna, PharmD


Alzheimer's disease represents a mounting public health problem and clinicians need a strong understanding of both the disease and its various treatment modalities.

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Advertisement
Latest Updated Articles
Managing Opioid- Induced ConstipationPublished: September 15th 2009 | Updated:
Alzheimer's Disease: Slowing Down the CoursePublished: March 1st 2009 | Updated:
Overactive Bladder Disease: Overcoming the Urge to GoPublished: January 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
5





